Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series Analysis

Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series Analysis

The 2019 novel coronavirus (COVID-19) pandemic has placed a significant strain on hepatitis programs and interventions (screening, diagnosis, and treatment) at a critical moment in the context of hepatitis C virus (HCV) elimination. We sought to quantify changes in Direct Acting Antiviral (DAA) util...

Full description

Bibliographic Details
Main Authors: Ahmad Shakeri, Natalia Konstantelos, Cherry Chu, Tony Antoniou, Jordan Feld, Katie J. Suda, Mina Tadrous
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Viruses
Subjects:
antivirals
hepatitis C
COVID-19
drug policy
time series
Online Access:https://www.mdpi.com/1999-4915/13/7/1314

Internet

https://www.mdpi.com/1999-4915/13/7/1314

Similar Items